
The use of SNRIs during pregnancy is associated with certain risks, including gestational hypertension and specific congenital anomalies. However, these risks should be weighed against the benefits of treating depression, requiring careful assessment on a case-by-case basis.
safety, obstetrics, drug safety, SNRI, complications, antidepressants, pregnancy, pharmacology, maternal health, mental health
safety, obstetrics, drug safety, SNRI, complications, antidepressants, pregnancy, pharmacology, maternal health, mental health
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
